Table 3.
Comparison of the PPCPM vs usual care on antihypertensive use
| Outcome | PPCPM (n = 259) | Usual care (n = 118) | P value |
|---|---|---|---|
| No. of changes to antihypertensive regimen, mean (SD) | 1.9 (1.5) | 1.1 (1.1) | <.001 |
| Type of changes to antihypertensive regimen during the 12‐mo follow‐up, No. (%) | |||
| New antihypertensive added | 216 (83) | 61 (52) | <.001 |
| Dose increase | 75 (29) | 41 (35) | .2588 |
| Switched to another class | 32 (12) | 11 (9) | .3903 |
| No. of antihypertensive agents at 12‐mo follow‐up, mean (SD) | 2.0 (1.1) | 2.28 (1.4) | .1806 |
| No. (%) of patients prescribed an: | |||
| ACEI or ARB | 176 (68) | 78 (66) | .7221 |
| Thiazide diuretic | 187 (72) | 69 (58) | .0081 |
| CCB | 144 (56) | 51 (43) | .0257 |
| β‐Blocker | 49 (19) | 49 (42) | <.001 |
| Other | 39 (15) | 33(28) | .0031 |
| Therapeutic inertiaa | 27.6 | 43.7 | <.0001 |
Categorical variables compared using chi‐square test; continuous variables compared using nonparametric Wilcoxon‐Mann‐Whitney test.
Data sources: VCU Health System and Center for Healthy Hearts.
Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; PPCPM, pharmacist‐physician collaborative practice model; SBP, systolic blood pressure; SD, standard deviation.
a
Therapeutic inertia = (number of visits BP not at goal – number of visits with a medication change)/total number of visits.